Regarding genetic alterations diagnosed by FISH on TMAs, 5.6% were MYCN gain tumours, 13.3% presented 1p36 deletion, 14.2% harboured 11q deletion and 34.9% showed 17q gain. This evidence concerns the gene MYCN and neoplasm.